Shujie Fu

644 total citations
11 papers, 260 citations indexed

About

Shujie Fu is a scholar working on Molecular Biology, Physiology and Immunology and Allergy. According to data from OpenAlex, Shujie Fu has authored 11 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Immunology and Allergy. Recurrent topics in Shujie Fu's work include Epigenetics and DNA Methylation (3 papers), Immune Cell Function and Interaction (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Shujie Fu is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Immune Cell Function and Interaction (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Shujie Fu collaborates with scholars based in China and United States. Shujie Fu's co-authors include Linglin Fu, Yanbo Wang, Chong Wang, Di Xu, Yan Wang, Heping Xu, Godhev K. Manakkat Vijay, Danyang He, Harinder Singh and Nathan Salomonis and has published in prestigious journals such as Nature Communications, Nature Immunology and Scientific Reports.

In The Last Decade

Shujie Fu

10 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujie Fu China 6 117 76 51 50 48 11 260
Katrine Graversen Denmark 6 205 1.8× 28 0.4× 56 1.1× 39 0.8× 114 2.4× 8 333
Annika Sünderhauf Germany 7 123 1.1× 63 0.8× 10 0.2× 5 0.1× 87 1.8× 11 280
Dorota Sobolewska-Sztychny Poland 8 153 1.3× 163 2.1× 13 0.3× 35 0.7× 35 0.7× 21 392
Biao Fang China 4 93 0.8× 88 1.2× 17 0.3× 62 1.2× 61 1.3× 4 460
Portia Gough United States 8 97 0.8× 80 1.1× 4 0.1× 29 0.6× 27 0.6× 13 286
Christine Lagaraine France 9 98 0.8× 163 2.1× 64 1.3× 14 0.3× 24 0.5× 15 320
Shengxuan Liu China 12 211 1.8× 24 0.3× 40 0.8× 12 0.2× 19 0.4× 26 372
Lena Erkert Germany 8 73 0.6× 74 1.0× 10 0.2× 18 0.4× 25 0.5× 12 205
Philippe Andrès France 11 46 0.4× 96 1.3× 27 0.5× 43 0.9× 31 0.6× 16 365
G Bernard France 5 119 1.0× 80 1.1× 22 0.4× 25 0.5× 52 1.1× 7 455

Countries citing papers authored by Shujie Fu

Since Specialization
Citations

This map shows the geographic impact of Shujie Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujie Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujie Fu more than expected).

Fields of papers citing papers by Shujie Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujie Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujie Fu. The network helps show where Shujie Fu may publish in the future.

Co-authorship network of co-authors of Shujie Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Shujie Fu. A scholar is included among the top collaborators of Shujie Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujie Fu. Shujie Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Yujie, Min Hu, Shujie Fu, et al.. (2025). The role of the SIX family in cancer development and therapy: Insights from foundational and cutting-edge research. Critical Reviews in Oncology/Hematology. 214. 104860–104860.
2.
Liu, Jiachen, et al.. (2024). FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway. Scientific Reports. 14(1). 29411–29411. 2 indexed citations
3.
Li, Qing, Xi Chen, Feng Gao, et al.. (2024). Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity. Nature Communications. 15(1). 5981–5981. 3 indexed citations
4.
Fu, Shujie, Zhengyu Jiang, Min Hu, et al.. (2024). STAMBPL1/TRIM21 Balances AXL Stability Impacting Mesenchymal Phenotype and Immune Response in KIRC. Advanced Science. 12(1). e2405083–e2405083. 5 indexed citations
5.
Liu, Jiachen, Min Hu, Banghua Zhang, et al.. (2024). GHITM regulates malignant phenotype and sensitivity to PD‐1 blockade of renal cancer cells via Notch signalling. Journal of Cellular and Molecular Medicine. 28(8). e18290–e18290. 2 indexed citations
7.
Liu, Wei, Yu Yan, Liang Li, et al.. (2022). Hylocereus undatus flower extract suppresses OVA-induced allergic asthma in BALb/c mice by reducing airway inflammation and modulating gut microbiota. Biomedicine & Pharmacotherapy. 153. 113476–113476. 13 indexed citations
8.
Wang, Qinghua, Bin Chen, Junjie Yang, et al.. (2022). Multiomics Analysis Reveals Aberrant Metabolism and Immunity Linked Gut Microbiota with Insomnia. Microbiology Spectrum. 10(5). e0099822–e0099822. 43 indexed citations
9.
Wang, Yan, Godhev K. Manakkat Vijay, Shujie Fu, et al.. (2021). Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation. Nature Immunology. 22(7). 904–913. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026